Samuele M Marcora1, Andrew B Lemmey, Peter J Maddison. 1. School of Sport, Health and Exercise Sciences, University of Wales-Bangor, and Department of Rheumatology, Gwynedd Hospital, Bangor, Wales, UK.
Abstract
OBJECTIVE: . A Phase II trial was performed as a preliminary test of the efficacy and safety of progressive resistance training (PRT) as adjunct treatment for rheumatoid cachexia. METHODS:Ten mildly disabled patients with well-controlled rheumatoid arthritis (RA) trained, on average, 2.5 times per week for 12 weeks. Ten age and sex matched RA patients with similar disease characteristics were non-randomly assigned to a control group. Body composition, physical function, and disease activity were assessed pre and post intervention period. RESULTS: Between group comparisons at followup by ANCOVA using baseline scores as covariate showed significant increases in fat-free mass (+1253 g, p = 0.004), total body protein (+1063 g, p = 0.044), and arm (+280 g, p = 0.005) and leg (+839 g, p = 0.001) lean mass (a proxy measure of total body skeletal muscle mass) in response to PRT with no exacerbation of disease activity. There was also a trend for loss of fat mass in the trunk (-752 g, p = 0.084) and a significant reduction in percent body fat (-1.1%, p = 0.047). Changes in body composition were associated with improvements in various measures of physical function. CONCLUSION: Intense PRT with adequate volume seems to be an effective and safe intervention for stimulating muscle growth in patients with RA. Pending confirmation of these results in a larger randomized controlled trial that includes patients with more active and severe disease, a similar PRT program should be included in the management of RA as adjunct treatment for cachexia.
RCT Entities:
OBJECTIVE: . A Phase II trial was performed as a preliminary test of the efficacy and safety of progressive resistance training (PRT) as adjunct treatment for rheumatoid cachexia. METHODS: Ten mildly disabled patients with well-controlled rheumatoid arthritis (RA) trained, on average, 2.5 times per week for 12 weeks. Ten age and sex matched RApatients with similar disease characteristics were non-randomly assigned to a control group. Body composition, physical function, and disease activity were assessed pre and post intervention period. RESULTS: Between group comparisons at followup by ANCOVA using baseline scores as covariate showed significant increases in fat-free mass (+1253 g, p = 0.004), total body protein (+1063 g, p = 0.044), and arm (+280 g, p = 0.005) and leg (+839 g, p = 0.001) lean mass (a proxy measure of total body skeletal muscle mass) in response to PRT with no exacerbation of disease activity. There was also a trend for loss of fat mass in the trunk (-752 g, p = 0.084) and a significant reduction in percent body fat (-1.1%, p = 0.047). Changes in body composition were associated with improvements in various measures of physical function. CONCLUSION: Intense PRT with adequate volume seems to be an effective and safe intervention for stimulating muscle growth in patients with RA. Pending confirmation of these results in a larger randomized controlled trial that includes patients with more active and severe disease, a similar PRT program should be included in the management of RA as adjunct treatment for cachexia.
Authors: Marianna S Thomas; David Newman; Olof Dahlqvist Leinhard; Bahman Kasmai; Richard Greenwood; Paul N Malcolm; Anette Karlsson; Johannes Rosander; Magnus Borga; Andoni P Toms Journal: Eur Radiol Date: 2014-05-29 Impact factor: 5.315
Authors: Sara R Piva; Samannaaz S Khoja; Frederico G S Toledo; Mary Chester-Wasko; G Kelley Fitzgerald; Bret H Goodpaster; Clair N Smith; Anthony Delitto Journal: Arthritis Care Res (Hoboken) Date: 2019-02-12 Impact factor: 4.794
Authors: Barbara Strasser; Gunther Leeb; Christoph Strehblow; Wolfgang Schobersberger; Paul Haber; Edmund Cauza Journal: Clin Rheumatol Date: 2010-10-08 Impact factor: 2.980
Authors: Thomas G Manfredi; Michael A Monteiro; Linda S Lamont; Maria F Singh; Mona Foldvari; Sebrina White; Arthur C Cosmas; Maria L Urso Journal: J Strength Cond Res Date: 2013-02 Impact factor: 3.775
Authors: Emalie Hurkmans; Florus J van der Giesen; Thea Pm Vliet Vlieland; Jan Schoones; E C H M Van den Ende Journal: Cochrane Database Syst Rev Date: 2009-10-07